% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • beachinv beachinv Feb 19, 2013 10:03 AM Flag

    New holders....

    Has anyone seen the new filings. Lots of new holders. Some very savy biotech funds. Besides FMR, RA Capital, Ayer Capital; we now also have Deer VII, Broadfin, Baker Bros, TFS CApital. Many multibillion dollar funds ready to add. Like that Baker Bros is a fundamental long healthcare fund that takes concentrated positions. Should be a great 2013 if the events line up properly....=)

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Baker Bros...... interesting, they took a large stake in the company bozo now claims he has been recommending - PCYC..... their basis is around $2.00. Baker Bros. also had a big stake in Pharmasset, which they purchased around $5.00 in 2007. Pharmasset was purchased by Gilead for $137.00 per share about two years later. Hmmm.....Gilead. Thats a name that has come up a few times on this board.

      • 1 Reply to bohemianclubman
      • Yeah multibillion dollar funds that are dedicated to healthcare do not initiate $1-2MM positions and leave them they will continue to add. Not worth their time to take small positions since they will not generate any alpha or returns above mkt rate. Baker Bros likes to have $10-$20MM positions - this is how they generate otperformance. Look for multibillon dollar funds to continue to add as we get closer to big events...=)

    • Yes, I saw that Beach. And don't forget that next Monday, February 25, Insmed is participating in the Canaccord Genuity Orphan Drug One-on-One Day in New York. Anyone know what that is all about?

      MONMOUTH JUNCTION, NJ--(Marketwire - Feb 6, 2013) - Insmed Incorporated ( NASDAQ : INSM ), a biopharmaceutical company focused on developing and commercializing inhaled therapies for patients battling serious orphan lung diseases that are often life-threatening, today announced that Will Lewis, President and Chief Executive Officer of Insmed, will be presenting a corporate overview at the following healthcare investor conferences this month.
      •Leerink Swann Global Healthcare Conference 2013 on Wednesday, February 13, 2013 at 1:30 p.m. (ET) at the Waldorf Astoria Hotel in New York City
      •The Canaccord Genuity Orphan Drug One-on-One Day on Monday, February 25, 2013 at the Omni Berkshire Place in New York City

11.81+0.47(+4.14%)11:50 AMEDT